Endothelin (ET) and its mRNA are present in human endometrium, Its exp
ression varies across the menstrual cycle, reaching maximal levels in
the pre-menstrual phase, Human endometrial epithelial cells are the ma
jor in-vitro source of ET, and its release is affected by the stage of
the menstrual cycle from which the endometrium is taken and by the cy
tokines transforming growth factor-beta(1) and interleukin-1 alpha. Th
e cyclical variation in both ET mRNA and protein expression across the
normal menstrual cycle, and the differences observed in abnormal uter
ine bleeding (specifically reduced immunoreactivity in luminal and gla
ndular epithelium in the endometrium of Norplant(R) users), are consis
tent with a;role for ET in the control of menstrual bleeding, The role
of epithelial cell ET is not yet understood, Whether this source of E
T is important in endometrial regeneration and repair following menstr
uation or in vasoconstriction to cease menstrual bleeding remains to b
e determined.